{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T14:38:27Z","timestamp":1742913507436,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":31,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071633304"},{"type":"electronic","value":"9781071633311"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-3331-1_25","type":"book-chapter","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T22:01:42Z","timestamp":1687644102000},"page":"351-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineering Cell Lines for Specific Human Leukocyte Antigen Presentation"],"prefix":"10.1007","author":[{"given":"Dongbin","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khai Lee","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tima","family":"Shamekhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Tian","family":"Ting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry C. C.","family":"Lim Kam Sian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Roest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian P.","family":"Vivian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pouya","family":"Faridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,25]]},"reference":[{"key":"25_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.molonc.2007.01.004","volume":"1","author":"Z Herceg","year":"2007","unstructured":"Herceg Z, Hainaut P (2007) Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis. Mol Oncol 1:26\u201341","journal-title":"Mol Oncol"},{"key":"25_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41587-021-01038-8","volume":"40","author":"C Chong","year":"2022","unstructured":"Chong C, Coukos G, Bassani-Sternberg M (2022) Identification of tumor antigens with immunopeptidomics. Nat Biotechnol 40:175\u2013188","journal-title":"Nat Biotechnol"},{"key":"25_CR3","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.3390\/cancers14204968","volume":"14","author":"RA Leon-Letelier","year":"2022","unstructured":"Leon-Letelier RA, Katayama H, Hanash S (2022) Mining the Immunopeptidome for antigenic peptides in cancer. Cancers (Basel) 14:4968","journal-title":"Cancers (Basel)"},{"key":"25_CR4","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1073\/pnas.1815239116","volume":"116","author":"NP Croft","year":"2019","unstructured":"Croft NP, Smith SA, Pickering J et al (2019) Most viral peptides displayed by class I MHC on infected cells are immunogenic. Proc Natl Acad Sci U S A 116:3112\u20133117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"25_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41577-020-0390-6","volume":"21","author":"D Dersh","year":"2021","unstructured":"Dersh D, Holly J, Yewdell JW (2021) A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion. Nat Rev Immunol 21:116\u2013128","journal-title":"Nat Rev Immunol"},{"key":"25_CR6","doi-asserted-by":"publisher","first-page":"1097871","DOI":"10.3389\/fimmu.2022.1097871","volume":"13","author":"JC Prinz","year":"2022","unstructured":"Prinz JC (2022) Immunogenic self-peptides - the great unknowns in autoimmunity: identifying T-cell epitopes driving the autoimmune response in autoimmune diseases. Front Immunol 13:1097871","journal-title":"Front Immunol"},{"key":"25_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1399-0039.1978.tb01233.x","volume":"11","author":"B Arce-Gomez","year":"1978","unstructured":"Arce-Gomez B, Jones EA, Barnstable CJ, Solomon E et al (1978) The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for beta2 microglobulin. Tissue Antigens 11:96\u2013112","journal-title":"Tissue Antigens"},{"key":"25_CR8","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1084\/jem.180.6.2163","volume":"180","author":"M Sugita","year":"1994","unstructured":"Sugita M, Brenner MB (1994) An unstable beta 2-microglobulin: major histocompatibility complex class I heavy chain intermediate dissociates from calnexin and then is stabilized by binding peptide. J Exp Med 180:2163\u20132171","journal-title":"J Exp Med"},{"key":"25_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/eji.1830210232","volume":"21","author":"E Mottez","year":"1991","unstructured":"Mottez E, Jaulin C, Godeau F et al (1991) A single-chain murine class I major transplantation antigen. Eur J Immunol 21:467\u2013471","journal-title":"Eur J Immunol"},{"key":"25_CR10","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/eji.1830241110","volume":"24","author":"L Lee","year":"1994","unstructured":"Lee L, McHugh L, Ribaudo RK et al (1994) Functional cell surface expression by a recombinant single-chain class I major histocompatibility complex molecule with a cis-active beta 2-microglobulin domain. Eur J Immunol 24:2633\u20132639","journal-title":"Eur J Immunol"},{"key":"25_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1073\/pnas.93.1.236","volume":"93","author":"K Toshitani","year":"1996","unstructured":"Toshitani K, Braud V, Browning MJ et al (1996) Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 93:236\u2013240","journal-title":"Proc Natl Acad Sci U S A"},{"key":"25_CR12","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.4049\/jimmunol.168.7.3145","volume":"168","author":"YY Yu","year":"2002","unstructured":"Yu YY, Netuschil N, Lybarger L et al (2002) Cutting edge: single-chain trimers of MHC class I molecules form stable structures that potently stimulate antigen-specific T cells and B cells. J Immunol 168:3145\u20133149","journal-title":"J Immunol"},{"key":"25_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1089\/ars.2010.3694","volume":"15","author":"E Kotsiou","year":"2011","unstructured":"Kotsiou E, Brzostek J, Gould KG (2011) Properties and applications of single-chain major histocompatibility complex class I molecules. Antioxid Redox Signal 15:645\u2013655","journal-title":"Antioxid Redox Signal"},{"key":"25_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1172\/JCI114984","volume":"87","author":"CM D'Urso","year":"1991","unstructured":"D'Urso CM, Wang ZG, Cao Y et al (1991) Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. J Clin Invest 87:284\u2013292","journal-title":"J Clin Invest"},{"key":"25_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.586168","volume":"11","author":"K Hoerster","year":"2020","unstructured":"Hoerster K, Uhrberg M, Wiek C et al (2020) HLA class I knockout converts allogeneic primary NK cells into suitable effectors for \"off-the-shelf\" immunotherapy. Front Immunol 11:586168","journal-title":"Front Immunol"},{"key":"25_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/jcmm.14778","volume":"24","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang Y, Shao L et al (2020) Knockout of beta-2 microglobulin reduces stem cell-induced immune rejection and enhances ischaemic hindlimb repair via exosome\/miR-24\/Bim pathway. J Cell Mol Med 24:695\u2013710","journal-title":"J Cell Mol Med"},{"key":"25_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.7150\/ijbs.64640","volume":"18","author":"D Zheng","year":"2022","unstructured":"Zheng D, Wang X, Zhang Z et al (2022) Engineering of human mesenchymal stem cells resistant to multiple natural killer subtypes. Int J Biol Sci 18:426\u2013440","journal-title":"Int J Biol Sci"},{"key":"25_CR18","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","volume":"95","author":"N Lee","year":"1998","unstructured":"Lee N, Llano M, Carretero M et al (1998) HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A. Proc Natl Acad Sci U S A 95:5199\u20135204","journal-title":"Proc Natl Acad Sci U S A"},{"key":"25_CR19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1096\/fj.09-135194","volume":"24","author":"B Favier","year":"2010","unstructured":"Favier B, Lemaoult J, Lesport E et al (2010) ILT2\/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse. FASEB J 24:689\u2013699","journal-title":"FASEB J"},{"key":"25_CR20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.3860","volume":"35","author":"GG Gornalusse","year":"2017","unstructured":"Gornalusse GG, Hirata RK, Funk SE et al (2017) HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nat Biotechnol 35:765\u2013772","journal-title":"Nat Biotechnol"},{"key":"25_CR21","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.add9665","volume":"378","author":"WA Lim","year":"2022","unstructured":"Lim WA (2022) The emerging era of cell engineering: harnessing the modularity of cells to program complex biological function. Science 378:848\u2013852","journal-title":"Science"},{"key":"25_CR22","volume-title":"Diffuse Intrinsic Pontine Glioma","author":"JE Pellot","year":"2022","unstructured":"Pellot JE, De Jesus O (2022) Diffuse Intrinsic Pontine Glioma. StatPearls, Treasure Island (FL)"},{"key":"25_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/medicines7050029","volume":"7","author":"SW Van Gool","year":"2020","unstructured":"Van Gool SW, Makalowski J et al (2020) Addition of multimodal immunotherapy to combination treatment strategies for children with DIPG: a single institution experience. Medicines (Basel) 7:29","journal-title":"Medicines (Basel)"},{"key":"25_CR24","doi-asserted-by":"publisher","first-page":"D784","DOI":"10.1093\/nar\/gku1166","volume":"43","author":"FF Gonzalez-Galarza","year":"2015","unstructured":"Gonzalez-Galarza FF, Takeshita LY, Santos EJ et al (2015) Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res 43:D784\u2013D788","journal-title":"Nucleic Acids Res"},{"key":"25_CR25","doi-asserted-by":"publisher","first-page":"eaar3947","DOI":"10.1126\/sciimmunol.aar3947","volume":"3","author":"P Faridi","year":"2018","unstructured":"Faridi P, Li C, Ramarathinam SH et al (2018) A subset of HLA-I peptides are not genomically templated: evidence for cis- and trans-spliced peptide ligands. Sci Immunol 3:eaar3947","journal-title":"Sci Immunol"},{"key":"25_CR26","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/s41596-019-0133-y","volume":"14","author":"AW Purcell","year":"2019","unstructured":"Purcell AW, Ramarathinam SH, Ternette N (2019) Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics. Nat Protoc 14:1687\u20131707","journal-title":"Nat Protoc"},{"key":"25_CR27","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1158\/2326-6066.CIR-19-0894","volume":"8","author":"P Faridi","year":"2020","unstructured":"Faridi P, Woods K, Ostrouska S, Deceneux C, Aranha R, Duscharla D et al (2020) Spliced peptides and cytokine-driven changes in the Immunopeptidome of melanoma. Cancer Immunol Res 8:1322\u20131334","journal-title":"Cancer Immunol Res"},{"key":"25_CR28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana NE, Shalem O, Zhang F (2014) Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods 11:783\u2013784","journal-title":"Nat Methods"},{"key":"25_CR29","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1038\/s41596-018-0075-9","volume":"13","author":"J Elegheert","year":"2018","unstructured":"Elegheert J, Behiels E, Bishop B et al (2018) Lentiviral transduction of mammalian cells for fast, scalable and high-level production of soluble and membrane proteins. Nat Protoc 13:2991\u20133017","journal-title":"Nat Protoc"},{"key":"25_CR30","doi-asserted-by":"publisher","first-page":"bpaa005","DOI":"10.1093\/biomethods\/bpaa005","volume":"5","author":"AC Pirona","year":"2020","unstructured":"Pirona AC, Oktriani R, Boettcher M et al (2020) Process for an efficient lentiviral cell transduction. Biol Methods Protoc 5:bpaa005","journal-title":"Biol Methods Protoc"},{"key":"25_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0301-4622(02)00057-1","volume":"97","author":"HE Davis","year":"2002","unstructured":"Davis HE, Morgan JR, Yarmush ML (2002) Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys Chem 97:159\u2013172","journal-title":"Biophys Chem"}],"container-title":["Methods in Molecular Biology","Inflammation and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3331-1_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T22:02:52Z","timestamp":1687644172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3331-1_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071633304","9781071633311"],"references-count":31,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3331-1_25","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"25 June 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}